🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. octocog alfa

    ADVATE Takeda

    EMA: approved

    B02BD02

  2. octreotide acetate

    OCTREOTIDE ACETATE Teva Pharma GmbH

    INJECTION FDA: approved

  3. oestrogens conjugated

    DUAVIVE

    EMA: approved

    G03CC07

  4. ointments, waxes

    NULL

    TGA: approved

  5. olanexidine gluconate

    OLANEDINE

    PMDA: approved

  6. olanzapine pamoate

    ZYPREXA RELPREVV

    INTRAMUSCULAR FDA: approved

  7. olezarsen sodium

    TRYNGOLZA (AUTOINJECTOR) IONIS PHARMACEUTICALS INC

    SUBCUTANEOUS FDA: approved

  8. olipudase alfa

    XENPOZYME

    EMA: approved · PMDA: approved

    A16AB25

  9. olipudase alfa-rpcp

    XENPOZYME

    INJECTION FDA: approved

  10. olive oil

    CLINOLIPID 20%

    INTRAVENOUS FDA: approved

  11. olive oil (use as additive only)

    NULL

    TGA: approved

  12. olmesartan + amlodipine

    OLMESARTAN/AMLODIPINE - MYL 20/5 Alphapharm Pty Ltd

    TGA: approved

  13. olmesartan + amlodipine + hydrochlorothiazide

    SEVIKAR HCT 20/5/12.5 Alphapharm Pty Ltd

    TGA: approved

  14. olmesartan + hydrochlorothiazide

    OLMESARTAN HCT - MYL 20/12.5 Alphapharm Pty Ltd

    TGA: approved

  15. olmesartan medoxomil

    BENICAR Amneal Pharma Europe Ltd

    ORAL FDA: approved

  16. olodaterol hydrochloride

    STRIVERDI RESPIMAT

    INHALATION FDA: approved

  17. olopatadine hydrochloride

    OLOPATADINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  18. olsalazine sodium

    DIPENTUM

    ORAL FDA: approved

  19. omacetaxine mepesuccinate

    TEKINEX Teva Pharma GmbH

    SUBCUTANEOUS FDA: approved · EMA: application withdrawn

    L01XX40

  20. omadacycline tosylate

    NUZYRA

    ORAL FDA: approved

  21. omalizumab-igec

    OMLYCLO

    INJECTION FDA: approved

  22. ombitasvir hydrate/paritaprevir hydrate/ritonavir

    VIEKIRAX INITIAL APPROVAL

    PMDA: approved

  23. omecamtiv mecarbil

    KINHARTO

    EMA: application withdrawn

    C01CX10

  24. omega-3-acid ethyl esters

    OMEGA-3-ACID ETHYL ESTERS Amneal Pharma Europe Ltd

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources